IL-15 transpresentation by ovarian cancer cells improves CD34⁺ progenitor-derived NK cell's anti-tumor functionality.

ABSTRACT: Ovarian cancer (OC) is the most lethal gynecological malignancy. As high numbers of Natural Killer (NK) cells in ascites associate with improved survival, the adoptive transfer of allogeneic NK cells is an attractive therapeutic strategy. An approach to further improve NK cell expansion and anti-tumor functionality post-infusion includes IL-15 transpresentation (transIL-15), which involves surface expression of the IL-15 cytokine bound to IL-15Rα. However, others have substantiated that systemic administration of ALT/N-803, a soluble molecule mimicking transIL-15, leads to T cell-mediated rejection of the infused allogeneic NK cell product. In addition, whether transIL-15 induce superior expansion and functionality of our hematopoietic progenitor cell-derived NK cells (HPC-NK) remains unde

SUBMITTER: Vidal-Manrique M 

PROVIDER: S-EPMC11834524 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature